Targeting immunoliposomes to EGFR-positive glioblastoma.
ESMO Open. 2022 Feb;7(1):100365. doi: 10.1016/j.esmoop.2021.100365. Epub 2022 Jan 5.
ESMO Open. 2022.
PMID: 34998092
Free PMC article.
Clinical Trial.